Clinical Trial Registry Policy Will Be Flexible For Phase II, Journal Editors Say
Executive Summary
Medical journal editors will apply a case-by-case analysis in determining whether to publish data from Phase II studies that have not been listed in public clinical trial registries, the International Committee of Medical Journal Editors said as the July 1 deadline for trial registration approaches